A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers.
about
Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial.Pathophysiology of Intestinal Na+/H+ exchange.Tenapanor administration and the activity of the H+ -coupled transporter PepT1 in healthy volunteers.Effect of Food Intake on the Pharmacodynamics of Tenapanor: A Phase 1 Study.Novel developments in differentiating the role of renal and intestinal sodium hydrogen exchanger 3.Understanding the Two Faces of Low-Salt Intake.Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders.Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers.Postprandial adjustments in renal phosphate excretion do not involve a gut-derived phosphaturic factor.Visceral Congestion in Heart Failure: Right Ventricular Dysfunction, Splanchnic Hemodynamics, and the Intestinal Microenvironment.A common NHE3 single-nucleotide polymorphism has normal function and sensitivity to regulatory ligands.Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis.
P2860
Q33639963-707B7B3C-BB78-463D-9F8B-09E6AD8BA0A4Q37585753-E53AED54-AA94-4BAB-A150-565F519280F6Q38692100-F0E3FFE4-D5FD-4333-95BC-74ED113F58D4Q38879346-28968462-022E-4B64-8929-BE226DA28D8EQ38979089-5808998A-F723-417C-896F-CAB20B146610Q39304736-FFC2D431-538B-48DE-BE60-383DB51F716AQ42025679-BD148660-1567-4F67-A3C6-0EC2B58538C2Q42094433-614D071B-F7EF-475F-93E9-A9535E1BCD1AQ48179198-1298C7EA-B035-4924-8CBE-5ACFEA728895Q48301736-FAE11F6B-83C0-46D4-8853-140638946852Q50093822-C51011CA-2A7B-42A1-A8CF-7F3959FDF243Q51007478-02C1DD7A-6C28-4716-ADD9-FAA248C08251Q55059919-3F94DB16-F6C2-403A-8D77-F65EFE4EAC59
P2860
A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A phase 1 study of the safety, ...... n healthy Japanese volunteers.
@ast
A phase 1 study of the safety, ...... n healthy Japanese volunteers.
@en
type
label
A phase 1 study of the safety, ...... n healthy Japanese volunteers.
@ast
A phase 1 study of the safety, ...... n healthy Japanese volunteers.
@en
prefLabel
A phase 1 study of the safety, ...... n healthy Japanese volunteers.
@ast
A phase 1 study of the safety, ...... n healthy Japanese volunteers.
@en
P2093
P2860
P1476
A phase 1 study of the safety, ...... in healthy Japanese volunteers
@en
P2093
Maria Leonsson-Zachrisson
Mikael Knutsson
Susanne Johansson
P2860
P2888
P304
P356
10.1007/S10157-016-1302-8
P577
2016-07-01T00:00:00Z